• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dare Bioscience Inc (NQ: DARE )

    4.210 -0.020 (-0.47%)
    Streaming Delayed Price Updated: 2:33 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Dare Bioscience Inc

    < Previous 1 2 3 4 Next >
    Earnings Outlook For Dare Bioscience
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning! 
    Via InvestorPlace
    Earnings Preview: Dare Bioscience
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Daré Bioscience Shares Move Higher Intravaginal Ring Shows Promise In Menopause Symptoms
    Via Benzinga
    HC Wainwright & Co. Maintains Buy Rating for Dare Bioscience: Here's What You Need To Know
    Via Benzinga
    Daré Bioscience's Intravaginal Ring Improves Vasomotor, Vaginal Symptoms Of Menopause
    Via Benzinga
    Dare Bioscience: Q1 Earnings Insights
    Dare Bioscience (NASDAQ:DARE) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Recap: Dare Bioscience Q4 Earnings
      Dare Bioscience (NASDAQ:DARE) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
    Via Benzinga
    Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
    Agile Therapeutics Inc. (NASDAQ: AGRX) is on a journey to fulfill the unmet health needs of women with products designed to provide them with contraceptive options. 
    Via Benzinga
    Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?
    From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,... 
    Via TheNewswire.com
    Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?
    By Ernest Dela Aglanu, Benzinga 
    Via News Direct
    Can This Company's Birth Control Patch Disrupt The Contraceptive Market?
    From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,... 
    Via Benzinga
    Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Earnings Outlook For Dare Bioscience
      Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Dare... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers 
    Via Benzinga
    President Biden Mulls Health Emergency For Abortion Access: Report
    Via Benzinga
    The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers 
    Via Benzinga
    EVFM Stock: Contraception Maker Evofem Biosciences Doubles After Roe Decision
    Evofem Biosciences is in the spotlight following the overturning of Roe v. Wade. Here's why EVFM stock is a name to watch. 
    Via InvestorPlace
    3 Women's Health Stocks Are Soaring Following Roe v. Wade Ruling
    Three days after the U.S. Supreme Court struck down Roe v. Wade in one of the most potentially impactful rulings of the last century, a handful of women's health stocks are on the move on Monday in... 
    Via Benzinga
    The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Earnings Preview: Dare Bioscience
    Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Dare... 
    Via Benzinga
    Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment
    Organon & Co (NYSE: OGN)  
    Via Benzinga
    Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
    From Organon & Co.
    Via Business Wire
    Earnings Preview: Dare Bioscience
    Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Dare... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers Orchard Therapeutics (NASDAQ:ORTX) stock moved upwards by 12.6% to $1.34 during Wednesday's pre-market session. The market value of their outstanding shares is... 
    Via Benzinga
    Earnings Scheduled For March 31, 2022
    Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers OptiNose (NASDAQ:OPTN) shares mov... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.